Clinical Trials Directory

Trials / Unknown

UnknownNCT04834713

Study on the Relationship Between Neutrophil-mediated Thrombocytopenia and the Condition and the Course of Disease in Patients With HFRS

Status
Unknown
Phase
Study type
Observational
Enrollment
28 (estimated)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Thrombocytopenia is an important pathological feature of HFRS(Hemorrhagic Fever With Renal Syndrome, HFRS). However, the cause of thrombocytopenia in HFRS is not yet fully understood. Neutrophils, as the largest number of white blood cells in the human body, can widely participate in the immune process of viral infections. Previous studies have found that the neutrophils of patients with acute myocardial infarction can interact with activated platelets and further mediate platelet phagocytosis.Therefore, this study aims to systematically elucidate the immunological process of neutrophil mediated thrombocytopenia in patients with HFRS by exploring the correlation between platelet activation, neutrophil activation and neutrophil proportion of adherent / phagocytic platelets peripheral blood of HFRS patients, and to analyze its relationship with the course of HFRS disease, which lays a theoretical foundation for further understanding the pathogenesis of HFRS and provides a basis for clinical use.

Conditions

Interventions

TypeNameDescription
OTHERclinical classification of HFRSBased upon clinical classification of HFRS , the patients were classified into four types

Timeline

Start date
2020-10-09
Primary completion
2024-02-28
Completion
2024-02-28
First posted
2021-04-08
Last updated
2021-09-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04834713. Inclusion in this directory is not an endorsement.